Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

HLA-B Antikörper (N-Term)

HLA-B Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB47637 unconjugated
Produktnummer ABIN1944779
  • Target Alle HLA-B Antikörper anzeigen
    HLA-B (Major Histocompatibility Complex, Class I, B (HLA-B))
    Bindungsspezifität
    • 11
    • 8
    • 7
    • 7
    • 6
    • 6
    • 5
    • 5
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    AA 75-107, N-Term
    Reaktivität
    • 92
    • 8
    • 8
    • 2
    Human
    Wirt
    • 63
    • 27
    • 2
    Kaninchen
    Klonalität
    • 67
    • 25
    Polyklonal
    Konjugat
    • 36
    • 15
    • 10
    • 8
    • 5
    • 5
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser HLA-B Antikörper ist unkonjugiert
    Applikation
    • 52
    • 46
    • 27
    • 17
    • 16
    • 8
    • 2
    • 2
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Aufreinigung
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogen
    This HLA-B antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 75-107 amino acids from the N-terminal region of human HLA-B.
    Klon
    RB47637
    Isotyp
    Ig Fraction
  • Applikationshinweise
    WB: 1:1000. WB: 1:1000. IHC-P: 1:25. IHC-P: 1:25. IHC-P: 1:25. IHC-P: 1:25
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Haltbarkeit
    6 months
  • Lin, Tokunaga, Tanaka, Nakajima, Imanishi, Kashiwase, Bannai, Mizuno, Akaza, Tadokoro, Shibata, Juji: "Further molecular diversity in the HLA-B15 group." in: Tissue antigens, Vol. 47, Issue 4, pp. 265-74, (1996) (PubMed).

    Hildebrand, Domena, Shen, Lau, Terasaki, Bunce, Marsh, Guttridge, Bias, Parham: "HLA-B15: a widespread and diverse family of HLA-B alleles." in: Tissue antigens, Vol. 43, Issue 4, pp. 209-18, (1994) (PubMed).

    Little, Parham: "The HLA-Bw75 subtype of B15: molecular characterization and comparison with crossreacting antigens." in: Tissue antigens, Vol. 38, Issue 4, pp. 186-90, (1992) (PubMed).

    Madrigal, Belich, Hildebrand, Benjamin, Little, Zemmour, Ennis, Ward, Petzl-Erler, du Toit: "Distinctive HLA-A,B antigens of black populations formed by interallelic conversion." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 149, Issue 10, pp. 3411-5, (1992) (PubMed).

    Watkins, McAdam, Liu, Strang, Milford, Levine, Garber, Dogon, Lord, Ghim: "New recombinant HLA-B alleles in a tribe of South American Amerindians indicate rapid evolution of MHC class I loci." in: Nature, Vol. 357, Issue 6376, pp. 329-33, (1992) (PubMed).

  • Target
    HLA-B (Major Histocompatibility Complex, Class I, B (HLA-B))
    Andere Bezeichnung
    HLA-B (HLA-B Produkte)
    Synonyme
    AS antikoerper, HLAB antikoerper, SPDA1 antikoerper, mhc1b antikoerper, major histocompatibility complex, class I, B antikoerper, major histocompatibility complex nonclassical class Ib L homeolog antikoerper, HLA-B antikoerper, BOLA-B antikoerper, MAMU-B18 antikoerper, DKFZP469N1225 antikoerper, mhc1b.L antikoerper
    Hintergrund
    Involved in the presentation of foreign antigens to the immune system.
    UniProt
    P30464
    Pathways
    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Sie sind hier:
Kundenservice